Sukumar Kalvapudi
Overview
Explore the profile of Sukumar Kalvapudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cortellini A, Brunetti L, Di Fazio G, Garbo E, Pinato D, Naidoo J, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39904562
Background: Pembrolizumab monotherapy is an established front-line treatment for advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) tumor proportion score (TPS)≥50%. However, real-world data on its...
2.
Smith Jr R, Zollo R, Kalvapudi S, Vedire Y, Pachimatla A, Petrucci C, et al.
J Natl Cancer Inst
. 2024 Nov;
PMID: 39560490
Background: Pre-clinical cancer studies ascribe promising anticancer properties to metformin. Yet, clinical findings vary, casting uncertainty on its therapeutic value for non-small cell lung cancer (NSCLC) patients. We hypothesized that...
3.
Ratnakaram K, Yendamuri S, Groman A, Kalvapudi S
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409866
Non-small cell lung cancer (NSCLC) has seen a relative rise in incidence among females versus males in recent years, although males still have a higher overall incidence. However, it is...
4.
Kalvapudi S, Pachimatla A, Seager R, Conroy J, Pabla S, Mukherjee S
Med Oncol
. 2024 Aug;
41(9):227.
PMID: 39143271
Gastroesophageal adenocarcinoma (GEAC) poses a significant challenge due to its poor prognosis and limited treatment options. Recently, Cancer/testis antigens (CTAs) have emerged as potential therapy targets due to their high...
5.
Smith Jr R, Gee K, Kalvapudi S, Pachimatla A, Swamidoss R, Vedire Y, et al.
J Thorac Cardiovasc Surg
. 2024 Jul;
169(3):764-776.e9.
PMID: 39019152
Objective: Lung cancer remains a major cause of mortality worldwide, necessitating further understanding of carcinogenesis and its driving factors, including those influenced by sex-dependent variables. We hypothesized that sex-specific lung...
6.
Kalvapudi S, Pachimatla A, Seager R, Conroy J, Pabla S, Mukherjee S
Res Sq
. 2024 Jul;
PMID: 38947068
Gastroesophageal adenocarcinoma (GEAC) poses a significant challenge due to its poor prognosis and limited treatment options. Recently, Cancer/testis antigens (CTAs) have emerged as potential therapy targets due to their high...
7.
Ivanick N, Kunadharaju R, Bhura S, Mengiste H, Saeed M, Saradna A, et al.
J Bronchology Interv Pulmonol
. 2024 Jun;
31(3).
PMID: 38881337
Background: The prevalence of malignant central airway obstruction at diagnosis and its 5-year incidence are largely unknown, as are basic epidemiological data pertaining to this serious condition. To address these...
8.
Kalvapudi S, Zubair H, Kunadharaju R, Bhura S, Mengiste H, Saeed M, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38610936
Background: Malignant Central Airway Obstruction (MCAO) presents a significant challenge in lung cancer management, with notable morbidity and mortality implications. While bronchoscopy is the established diagnostic standard for confirming MCAO...
9.
Venkatesan S, Kalvapudi S, Muppidi V, Ajith K, Dutt A, Madhugiri V
Acta Neurochir (Wien)
. 2024 Mar;
166(1):150.
PMID: 38528271
Purpose: Surveys generate valuable data in epidemiologic and qualitative clinical research. The quality of a survey depends on its design, the number of responses it receives, and the reporting of...
10.
Kalvapudi S, Vedire Y, Yendamuri S, Barbi J
Front Oncol
. 2023 Dec;
13:1286104.
PMID: 38144524
Introduction: Survival rates for early-stage non-small cell lung cancer (NSCLC) remain poor despite the decade-long established standard of surgical resection and systemic adjuvant therapy. Realizing this, researchers are exploring novel...